On August 15, 2005, the Food and Drug Administration (FDA) and the Association of American Medical Colleges released a joint report that examines possible steps to accelerate drug discovery and development. The report, entitled Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government, is the product of a two-day conference among leaders from the pharmaceutical industry, academia, and FDA. The goal of the conference and the report was to explore means of overcoming the high failure rate for tentative drug candidates
The research, development, and approval of a drug product is a continuous but lengthy process involv...
Drug discovery development and commercialization explains how a drug is discovered and is allowed fo...
I am honored to have been asked by the editors of the University of Illinois Law Review to comment o...
In May 2005, the Food and Drug Administration (FDA) issued draft guidance on the type of information...
In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating th...
FDA to Create Drug Safety Board In February 2005, the Food and Drug Administration (FDA) announced t...
The rate of new drug approvals in the US has remained essentially constant since 1950, while the cos...
Welcome to the 3rd issue of the Journal of Medicines Development Sciences. Like previous issues it c...
In spite of a growing literature on pharmaceuticalization, little is known about the pharmaceutical ...
Biotechnology advances have the potential to dramatically change the practice of medicine. Currently...
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2004.Includes bibliographical...
Biopharmaceutical development is characterized by challenging regulations, intense competition and s...
For latest version: please go to https://academicentrepreneurship.pubpub.org/pub/8a05fz36/release/4 ...
Background: The U.S Food and Drugs Administration (FDA) is the world's leading drug regulatory autho...
The United States (US) Food and Drug Administration (FDA) approves new drugs based on sponsor-submit...
The research, development, and approval of a drug product is a continuous but lengthy process involv...
Drug discovery development and commercialization explains how a drug is discovered and is allowed fo...
I am honored to have been asked by the editors of the University of Illinois Law Review to comment o...
In May 2005, the Food and Drug Administration (FDA) issued draft guidance on the type of information...
In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating th...
FDA to Create Drug Safety Board In February 2005, the Food and Drug Administration (FDA) announced t...
The rate of new drug approvals in the US has remained essentially constant since 1950, while the cos...
Welcome to the 3rd issue of the Journal of Medicines Development Sciences. Like previous issues it c...
In spite of a growing literature on pharmaceuticalization, little is known about the pharmaceutical ...
Biotechnology advances have the potential to dramatically change the practice of medicine. Currently...
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2004.Includes bibliographical...
Biopharmaceutical development is characterized by challenging regulations, intense competition and s...
For latest version: please go to https://academicentrepreneurship.pubpub.org/pub/8a05fz36/release/4 ...
Background: The U.S Food and Drugs Administration (FDA) is the world's leading drug regulatory autho...
The United States (US) Food and Drug Administration (FDA) approves new drugs based on sponsor-submit...
The research, development, and approval of a drug product is a continuous but lengthy process involv...
Drug discovery development and commercialization explains how a drug is discovered and is allowed fo...
I am honored to have been asked by the editors of the University of Illinois Law Review to comment o...